Sijia Yu

821 total citations
40 papers, 473 citations indexed

About

Sijia Yu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Sijia Yu has authored 40 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Cardiology and Cardiovascular Medicine and 8 papers in Oncology. Recurrent topics in Sijia Yu's work include Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Heart Failure Treatment and Management (3 papers). Sijia Yu is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Chronic Kidney Disease and Diabetes (3 papers) and Heart Failure Treatment and Management (3 papers). Sijia Yu collaborates with scholars based in China, United States and United Kingdom. Sijia Yu's co-authors include Maosheng Cheng, Chenzhou Hao, Tianxiao Wu, Dongmei Zhao, Bowen Yang, Yixuan Chen, Ruifeng Wang, Shiqun Chen, Song Jun-mei and Jin Liu and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and New Phytologist.

In The Last Decade

Sijia Yu

38 papers receiving 465 citations

Peers

Sijia Yu

ONCOL

CCM

Graziella Malaponte Italy

Yuichi Shinozaki Japan

Wafaey Gomaa Saudi Arabia

Sandra K. Wittmann Germany

Christine Heinzle Austria

Jiří Knížek Czechia

Iwao Yamada Japan

Hassan A. Hamali Saudi Arabia

Latha Paka United States

Graziella Malaponte Italy

Sijia Yu

241 ×1.1

125 ×1.4

ONCOL

67 ×1.0

47 ×0.8

26 ×0.5

CCM

Citations per year, relative to Sijia Yu Sijia Yu (= 1×) peers Graziella Malaponte

Countries citing papers authored by Sijia Yu

Since Specialization

Citations

This map shows the geographic impact of Sijia Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sijia Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sijia Yu more than expected).

Fields of papers citing papers by Sijia Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sijia Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sijia Yu. The network helps show where Sijia Yu may publish in the future.

Co-authorship network of co-authors of Sijia Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Sijia Yu. A scholar is included among the top collaborators of Sijia Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sijia Yu. Sijia Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Sijia, et al.. (2025). Residual cholesterol inflammatory index and its prognostic role in mortality among individuals with cardiovascular–kidney–metabolic syndrome stages 0–3 based on U.S. and Chinese national cohorts. European journal of medical research. 31(1). 35–35.

Yu, Sijia, et al.. (2025). Association between the triglyceride glucose body mass index and asthma: evidence from NHANES 2011–2018. BMC Pulmonary Medicine. 25(1). 51–51. 1 indexed citations

Yu, Sijia, et al.. (2024). Efficacy and safety of repeated transcranial magnetic stimulation combined with escitalopram in the treatment of major depressive disorder: a meta-analysis. Frontiers in Psychiatry. 14. 1275839–1275839. 1 indexed citations

Yu, Sijia, et al.. (2023). Pre-RNA splicing in metabolic homeostasis and liver disease. Trends in Endocrinology and Metabolism. 34(12). 823–837. 8 indexed citations

He, Yibo, Chang Tian, Sijia Yu, et al.. (2023). Intermediate Hyperglycemia Increases the Risk of All-Cause Mortality in Premature Coronary Artery Disease Patients Undergoing Percutaneous Coronary Intervention. Reviews in Cardiovascular Medicine. 24(12). 352–352. 2 indexed citations

Yu, Sijia, et al.. (2023). Mechanisms of Obesity-Induced Changes in Pharmacokinetics of IgG in Rats. Pharmaceutical Research. 40(5). 1223–1238. 1 indexed citations

He, Yibo, Hongyu Lu, Jin Liu, et al.. (2023). Prediabetes and all-cause mortality in young patients undergoing coronary artery angiography: a multicenter cohort study in China. Cardiovascular Diabetology. 22(1). 42–42. 5 indexed citations

He, Yibo, Wei Guo, Yukun Zhao, et al.. (2023). Association of N-terminal pro-B-type natriuretic peptide (NT-proBNP) and acute kidney disease in patients undergoing coronary angiography: a cohort study. International Urology and Nephrology. 55(8). 2067–2073. 2 indexed citations

Luo, Lixin, Sijia Yu, Jing Yang, et al.. (2022). The DnaJ domain‐containing heat‐shock protein NAL11 determines plant architecture by mediating gibberellin homeostasis in rice (Oryza sativa). New Phytologist. 237(6). 2163–2179. 10 indexed citations

10.

Li, Huanqiang, Bo Wang, Sijia Yu, et al.. (2022). Paradoxical Association Between Baseline Apolipoprotein B and Prognosis in Coronary Artery Disease: A 36,460 Chinese Cohort Study. Frontiers in Cardiovascular Medicine. 9. 822626–822626. 3 indexed citations

11.

Zhao, Xiaoli, Zhidong Huang, Yun Xie, et al.. (2022). Elevation of Preprocedural Systemic Immune Inflammation Level Increases the Risk of Contrast-Associated Acute Kidney Injury Following Coronary Angiography: A Multicenter Cohort Study. Journal of Inflammation Research. Volume 15. 2959–2969. 9 indexed citations

12.

Xie, Yun, Xiaoli Zhao, Sijia Yu, et al.. (2022). Elevated systemic immune inflammation level increases the risk of total and cause-specific mortality among patients with chronic kidney disease: a large multi-center longitudinal study. Inflammation Research. 72(1). 149–158. 38 indexed citations

13.

Zheng, Chengkun, et al.. (2022). The AdcR-regulated AdcA and AdcAII contribute additively to zinc acquisition and virulence in Streptococcus suis. Veterinary Microbiology. 269. 109418–109418. 7 indexed citations

14.

Li, Huanqiang, Sijia Yu, Bo Wang, et al.. (2021). Exploring the Pleiotropic Genes and Therapeutic Targets Associated with Heart Failure and Chronic Kidney Disease by Integrating metaCCA and SGLT2 Inhibitors’ Target Prediction. BioMed Research International. 2021(1). 4229194–4229194. 3 indexed citations

15.

Zhu, Dandan, Xuemei Tan, Liqing Lu, et al.. (2021). Interplay between nuclear factor erythroid 2-related factor 2 and inflammatory mediators in COVID-19-related liver injury. World Journal of Gastroenterology. 27(22). 2944–2962. 15 indexed citations

16.

Li, Dezhi, et al.. (2020). Silence of lncRNA MIAT-mediated inhibition of DLG3 promoter methylation suppresses breast cancer progression via the Hippo signaling pathway. Cellular Signalling. 73. 109697–109697. 32 indexed citations

17.

Yu, Sijia & Santiago Vernia. (2020). A Transposon-Based Mouse Model of Hepatocellular Carcinoma via Hydrodynamic Tail Vein Injection. Methods in molecular biology. 2164. 129–143. 1 indexed citations

18.

Wang, Ruifeng, Sijia Yu, Yixuan Chen, et al.. (2020). Discovery of 7H-pyrrolo[2,3-d]pyridine derivatives as potent FAK inhibitors: Design, synthesis, biological evaluation and molecular docking study. Bioorganic Chemistry. 102. 104092–104092. 24 indexed citations

19.

Wang, Ruifeng, Yixuan Chen, Bowen Yang, et al.. (2019). Design, synthesis, biological evaluation and molecular modeling of novel 1H-pyrrolo[2,3-b]pyridine derivatives as potential anti-tumor agents. Bioorganic Chemistry. 94. 103474–103474. 24 indexed citations

20.

Wang, Ruifeng, Yixuan Chen, Sijia Yu, et al.. (2019). Design, synthesis and biological evaluation of novel 7H-pyrrolo[2,3-d]pyrimidine derivatives as potential FAK inhibitors and anticancer agents. European Journal of Medicinal Chemistry. 183. 111716–111716. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact